Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SurGenTec
Boca Raton, Florida, United Statessurgentec.com ↗
- Ownership
- Private
- Employees
- ~50
- Development stage
- Commercial
01
Overview
SurGenTec has received multiple FDA 510(k) clearances for its innovative orthopedic and spine technologies. Its flagship products—such as the OsteoFlo HydroPutty synthetic bone graft and the 3D GraftRasp System—have demonstrated excellent preclinical results in terms of bone growth and integration. The company’s solutions are used both domestically in the US and internationally[3][5].
- Therapeutic areas
- OtherRheumatologyNeurology
- Modalities
- DeviceSynthetic biologicBone graft substituteBiologicCellular matrixAllograft material
- Industry
- Implantable Medical Devices
02
Partnerships
None publicly disclosed as of June 2025.
Beyond the preview
Go deeper on SurGenTec.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SurGenTec.